Wikisage, the free encyclopedia of the second generation, is digital heritage
Oxcarbazepine: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
mNo edit summary |
||
Line 1: | Line 1: | ||
a derivative of carbamazepine acts by blockade of sodium channels <ref>http://www.scielo.br/pdf/spmj/v127n3/a08v1273.pdf Oxcarbazepine for refractory epilepsy: | a derivative of carbamazepine acts by blockade of sodium channels <ref>[http://www.scielo.br/pdf/spmj/v127n3/a08v1273.pdf Oxcarbazepine for refractory epilepsy:systematic review of the literature ]</ref> | ||
systematic review of the literature </ref> | |||
<gallery> | <gallery> | ||
File:Trileptal_Oral_Suspension_100mg_per_ml.JPG</gallery> | File:Trileptal_Oral_Suspension_100mg_per_ml.JPG | ||
</gallery> | |||
==ATC== | ==ATC== | ||
https://www.whocc.no/atc_ddd_index/?code=N03AF02 | |||
[https://www.whocc.no/atc_ddd_index/?code=N03AF02] | |||
==Links== | ==Links== | ||
Line 17: | Line 19: | ||
<references/> | <references/> | ||
[[Category:Anticonvulsants]] |
Revision as of 03:04, 5 May 2017
a derivative of carbamazepine acts by blockade of sodium channels [1]
ATC
Links
Stevens–Johnson_syndrome
Oxtellar is a XR form http://reference.medscape.com/drug/trileptal-oxtellar-xr-oxcarbazepine-343014
https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM406335.pdf